Precise: Estudio de los nacimientos y la tasa de fertilidad adolescente en adolescentes chilenas, evaluación de desigualdad y su asociación a factores sociodemográficos. Responsable de la correspondencia: Nombre: Sebastián Lavanderos
Background Cancer patients may be at higher risk for severe coronavirus infectious disease-19 (COVID-19); however, the outcome of Primary Central Nervous System Lymphoma (PCNSL) patients with SARS-CoV-2 infection has not been described yet. Methods We conducted a retrospective study within the Lymphomes Oculo-Cérébraux national network (LOC) to assess the clinical characteristics and outcome of SARS-CoV-2 infection in PCNSL patients (positive real-time polymerase chain reaction of nasopharyngeal swab or evocative lung computed tomography scan). We compared clinical characteristics between patients with severe (death and/or intensive care unit admission) and mild disease. Results Between March and May 2020, 13 PCNSL patients were diagnosed with SARS-CoV-2 infection, 11 (85%) of whom were undergoing chemotherapy at the time of infection. The mortality rate was 23% (3/13), and two additional patients (15%) required mechanical ventilation. Two patients (15%) had no COVID-19 symptoms. History of diabetes mellitus was more common in severe patients (3/5 vs 0/8, p = 0.03). Two patients recovered from COVID-19 after mechanical ventilation during more than two weeks and resumed chemotherapy. In all, chemotherapy was resumed after COVID-19 recovery in nine patients (69%) after a median delay of 16 days (range 3-32), none of whom developed unusual chemotherapy complication nor SARS-Cov2 reactivation. Conclusion This preliminary analysis suggests that, while being at higher risk be for severe illness, PCNSL patients with COVID-19 might be treated maximally especially if they achieved oncological response at the time of SARS-CoV-2 infection. Chemotherapy might be resumed without prolonged delay in PCNSL patients with COVID-19.
Socio-demographic profiles are associated with the age at death due to cardiovascular diseases. The effect of not receiving medical care on the age at death is noteworthy and reflects social inequities in the access to health care.
ResumenEl presente estudio analiza y describe la relación entre la identidad profesional y las preferencias profesionales, en los estudiantes del Programa Profesional de Administración de Negocios de la Universidad Católica San Pablo.Para ello, se utilizó como instrumentos el Cuestionario de Identidad Profesional de Walter Arias y el Inventario de Preferencias Profesionales de José Luis Pereyra. La muestra estuvo conformada por 117 estudiantes del noveno y décimo semestre matriculados el periodo académico 2015-I. Se obtuvieron como resultados que el solo 27% de estudiantes de la muestra tienen una preferencia por la carrera de Administración. Se presentan también análisis descriptivos, comparativos y de correlación, de los datos recabados. Palabras clave: Identidad profesional, preferencias profesionales, administración de negocios.
AbstractThis study analyzes and describes the relationship between the professional identity and occupational preferences, in the students of administration of St. Pablo Catholic University. For this, we used the Questionnaire instruments of Professional Identity of Walter Arias and the Inventory of occupational preferences of José Luis Pereira. The sample consisted of 117 students in ninth and tenth semester of the academic year 2015-I.They were obtained as results that only 27% of students in the sample have a preference for management. Comparative, descriptive and analysis of correlation of the data collected are also presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.